Detection of oncogenic viruses (SV40, BKV, JCV, HCMV, HPV) and p53 codon 72 polymorphism in lung carcinoma

Lung Cancer

Volumn 57, Issue 3, 2007, Pages 273-281

  Giuliani, Laura ^a   Jaxmar, Terese ^a   Casadio, Caterina ^b   Gariglio, Marisa ^b   Manna, Assunta ^c   D'Antonio, Domenico ^c   Syrjanen, Kari ^d   Favalli, Cartesio ^a   Ciotti, Marco ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c SPIRITO SANTO HOSPITAL   (Italy)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Coinfections; HCMV; HPV; Lung cancer; p53 polymorphism; PCR; Polyomaviruses

Indexed keywords

ADULT; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TUMOR VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; BK VIRUS; CARCINOMA; CODON; CYTOMEGALOVIRUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JC VIRUS; LUNG NEOPLASMS; MALE; ONCOGENIC VIRUSES; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SIMIAN VIRUS 40; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548016812     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.02.019     Document Type: Article

References (52)

1. Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22 (2003) 5131-5140
2. Macsween K.F., and Crawford D.H. Epstein-Barr virus-recent advances. Lancet Infect Dis 3 (2003) 131-140
3. Ganem D. KHSV and Kaposi's sarcoma: the end of the beginning?. Cell 91 (1997) 157-160
4. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92 (2000) 690-698
5. Barbanti-Brodano G., Sabbioni S., Martini F., Negrini M., Corallini A., and Tognon M. Simian virus 40 infection im humans and association with human diseases: results and hypotheses. Virology 318 (2004) 1-9
6. White M.K., and Khalili K. Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorogenesis. Virology 324 (2004) 1-16
7. Dolcetti R., Martini F., Quaia M., Gloghini A., Vignocchi B., Cariati R., et al. Simian virus 40 sequences in human lymphoblastoid B cell lines. J Virol 77 (2003) 1595-1597
8. Carbone M., Pass H.I., Miele L., and Bocchetta M. New developments abouts association of SV40 with human mesothelioma. Oncogene 22 (2003) 5173-5180
9. Arrington A.S., and Butel J.S. SV40 and human tumors. In: khalili K., and Stoner G.L. (Eds). Human polyomaviruses: molecular and clinical perspective (2001), Wiley-Liss, New York 461-489
10. Carbone M., Rizzo P., Grimley P.M., Procopio A., Mew D.J., Shridhar V., et al. Simian virus 40 large T antigen bind p53in human mesotheliomas. Nat Med 3 (1997) 908-912
11. Cobbs C.S., Harkins L., Samanta M., Gillespie G.Y., Bharara S., King P.H., et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 6233 (2002) 47-50
12. Samanta M., Harkins L., Klemm K., Britt W.J., and Cobbs C.S. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170 (2003) 998-1002
13. Harkins L., Volk A.L., Samanta M., Mikolaenko I., Britt W.J., Bland K.I., et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360 (2002) 1557-1563
14. Michaelis R., Kotchetkov R., Vogel J.U., Doerr H.W., and Cinatl Jr. J. Cytomegalovirus infection blocks apoptosis in cancer cell. Cell Mol Life Sci 61 (2004) 1307-1316
15. Hsu C.H., Chang M.D.T., Tai K.Y., Yang Y.T., Wang P.S., Chen C.J., et al. HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J 23 (2004) 2269-2280
16. De Viliers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
17. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosh F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
18. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990) 1129-1136
19. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus Types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
20. Dyson N., Howley P.M., Munger K., and Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 (1989) 934-937
21. Syrjänen K., and Syrjänen S. Papillomavirus Infections in Human Pathology (2000), J Wiley & Sons, New York p. 1-615
22. Alberg A.J., and Samet J.M. Epidemiology of lung cancer. Chest 123 (2003) 21S-49S
23. Jain N., Singh V., Hedau S., Kumar S., Daga M.K., Dewan R., et al. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 128 (2005) 3999-4007
24. Gorgoulis V.G., Zacharatos P., Kotsinas A., Kyroudi A., Rassidakis A.N., Ikonomopoulos J.A., et al. Human papillomavirus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 30 (1999) 274-283
25. Welt A., Hummel M., Niedobitek G., and Stein H. Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase chain reaction. J Pathol 181 (1997) 276-280
26. Ciotti M., Giuliani L., Ambrogi V., Ronci C., Benedetto A., Mineo T.C., et al. Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep 16 (2006) 183-189
27. Grinstein S., Preciado M.V., Gattuso P., Chabay P.A., Warren W.H., De Matteo E., et al. Demonstration of Epstein-barr virus in carcinomas of various sites. Cancer Res 62 (2002) 4876-4878
28. Galateau-Salle F., Bidet P., Iwatsubo Y., Gennetay E., Renier A., Letourneux M., et al. Detection of SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma and other pulmonary diseases. Dev Biol Stand 94 (1998) 147-152
29. Brouchet L., Valmary S., Dahan M., Didier A., Galateau-Salle F., Brousset P., et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 92 (2005) 743-746
30. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16 (1988) 1215
31. Strassburg C.P., Strassburg A., Nguyen N., Li Q., Manns M.P., and Tukey R.H. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem J 338 (1999) 489-498
32. Lednicky J.A., Stewart A.R., Jenkins J.J., Finegold M.J., and Butel J.S. SV40 DNA in human osteosarcoma shows sequence variations among T-antigen genes. Int J Cancer 72 (1997) 791-800
33. Arthur R.R., Dagostin S., and Shah K. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol 27 (1989) 1174-1179
34. Ferrante P., Cardarelli-Stefano R., Omodeo-Zorini E., Vago L., Boldorini R., and Costanzi G. PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy. J Med Virol 47 (1995) 219-225
35. Evander M., Edlund K., Boden E., Gustfsson A., Jonsson M., Karlsson R., et al. Comparision of one-step and two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol 30 (1992) 987-992
36. Fenner T.E., Garweg J., Huferf F.T., Boehnke M., and Schmitz H. Diagnosis of human cytomegalovirus-induced retinitis in human immunodeficiency virus type 1-infected subjects by using the polymerase chain reaction. J Clin Microbiol 29 (1991) 2621-2622
37. Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M., et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153 (1998) 1731-1739
38. Fujinaga Y., Shimada M., Okazawa K., Fukushima K., Kato I., and Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 72 (1991) 1039-1044
39. Lee J.M., Shun C.T., Wu M.T., Chen Y.Y., Yang S.Y., Hung H.I., et al. The association of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer. Mut Res/Funf Mol Mech Mut 594 (2006) 181-188
40. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1. 0. IARC cancer base (2000-2001), IARC Press, Lyon
41. Syrjänen K.J. Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration 38 (1979) 299-304
42. Syrjänen K.J. HPV infections and lung cancer. J Clin Pathol 55 (2002) 885-891
43. Corden S.A., Sant-Cassia L.J., Easton A.J., and Morris A.G. The integration of HPV-DNA 18 in cervical carcinoma. J Clin Pathol Mol Pathol 52 (1999) 275-282
44. Cheng Y.W., Chiou H.L., Sheu G.T., Hsieh L.L., Chen J.T., Chen C.Y., et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61 (2001) 2799-2803
45. Soriano F., Shelburne C.E., and Gokcen M. Simian virus 40 in a human cancer. Nature 249 (1974) 421-424
46. Del Valle L., Gordon J., Assimakopolou M., Enam S., Geddes J.F., Varakis J.N., et al. Detection of JC virus DNA sequences and expression of the viral regulatory protein, T-antigen, in tumors of the central nervous system. Cancer Res 61 (2001) 4287-4293
47. Enam S., Del Valle L., Lara C., Gan D.D., Ortiz-Hidalgo C., Palazzo J.P., et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 2 (2002) 7093-7101
48. Corallini A., Tognon M., Negrini M., and Barbanti-Brodano G. Evidence for BK virus as a human tumor virus. In: Khalili K., and Stoner G.L. (Eds). Human polyomaviruses: molecular and clinical perspective (2001), Wiley-Liss, New York 431-460
49. Szymanowska A., Jassem E., Dziadziuszko, Borg A., Limon J., Kobierska-Gulida G., et al. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 52 (2006) 9-14
50. Hu Y., Mcdermott M.P., and Ahrendt S.A. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Clin Cancer Res 11 7 (2005) 2502-2509
51. Storey A., Thomas M., Kalita A., Harwood C., Gardi D., Mantovani F., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234
52. Hori R., Muraai Y., Tsuneyama K., Abdel-Aziz H.O., Nomoto K., Takahashi H., et al. Detection of JC virus sequences in colorectal cancers in Japan. Virchows Arch 447 (2005) 723-730